Cel
Approximately 17% of human cancer cases occurring world-wide are caused by one of 6 human viruses, Human papillomavirus (HPV), Epstein Barr virus (EBV), Hepatitis B virus (HBV), Hepatitis C virus (HCV), Human herpesvirus 8 (HHV8; Kaposi´s sarcoma herpesvir us) and Human T- cell leukemia virus I (HTLV-I). In addition, the bacterium Helicobacter pylori is the infectious agent responsible for the second highest number of infection-associated cancers and additional infectious etiologies of cancer are likely to e xist. The INCA Integrated Project aims towards a better understanding of (1) the molecular and cellular circuits involved in the development of cancers caused by these infectious agents, (2) the mechanisms of long-term persistence of these infectious agent s in apparently healthy hosts, and (3) which genetic factors contribute to cancer development. Based on this knowledge INCA will develop and validate (4) animal models to study chronic inflammation and cancer progression, and (5) new diagnostic procedures for the identification of infected individuals likely to develop infection-associated malignancies. This will ultimately lead to (6) the identification of new drugs and procedures to interfere with processes that are central to the development of infection -associated cancer. The results of this joint effort will contribute to our understanding of malignant transformation and provide us with new tools to address an urgent socio-economic and human need. The INCA consortium will take a multi-disciplinary appro ach to the realisation of these goals and brings together scientists including SMEs from different backgrounds, who will work at all levels of a prevention and therapy-oriented process. The organisation of the research themes and joint activities in INCA s ubprojects will ensure the rapid spread of new findings into the entire programme. Professional management will promote efficient integration, realisation of scientific objectives & knowledge dissemination.
Dziedzina nauki
Zaproszenie do składania wniosków
FP6-2004-LIFESCIHEALTH-5
Zobacz inne projekty w ramach tego zaproszenia
System finansowania
IP - Integrated ProjectKoordynator
HANNOVER
Niemcy
Zobacz na mapie
Uczestnicy (27)
INNSBRUCK
Zobacz na mapie
THESSALONIKI
Zobacz na mapie
PARIS
Zobacz na mapie
VIENNA
Zobacz na mapie
GÖTEBORG
Zobacz na mapie
HEIDELBERG
Zobacz na mapie
TUEBINGEN
Zobacz na mapie
GEMBLOUX
Zobacz na mapie
ERLANGEN
Zobacz na mapie
248 BASEL
Zobacz na mapie
HELSINGIN YLIOPISTO, HELSINKI
Zobacz na mapie
LONDON
Zobacz na mapie
PARIS
Zobacz na mapie
PORTO
Zobacz na mapie
LYON
Zobacz na mapie
STOCKHOLM
Zobacz na mapie
COPENHAGEN
Zobacz na mapie
MUENCHEN
Zobacz na mapie
HANNOVER
Zobacz na mapie
SOLNA
Zobacz na mapie
BIRMINGHAM
Zobacz na mapie
PADOVA
Zobacz na mapie
LEEDS
Zobacz na mapie
MODENA
Zobacz na mapie
JENA
Zobacz na mapie
BORDEAUX CEDEX
Zobacz na mapie
BUDAPEST
Zobacz na mapie